CEP 751

Known as: CEP-751, CEP751 
 

Topic mentions per year

Topic mentions per year

1997-2006
01219972006

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
CONTEXT Medullary thyroid cancer (MTC) is a cancer of the parafollicular C cells that commonly presents with an inherited or… (More)
Is this relevant?
2004
2004
CEP-2563 dihydrochloride (CEP-2563) is a soluble lysinyl-β-alanyl ester of CEP-751, a potent inhibitor of the trk family of… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2003
2003
All of the cases of medullary thyroid carcinoma (MTC) express the RET receptor tyrosine kinase. In essentially all of the… (More)
Is this relevant?
2003
2003
All of the cases of medullary thyroid carcinoma (MTC) express the RET receptor tyrosine kinase. In essentially all of the… (More)
  • figure 2
  • figure 1
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2001
2001
BACKGROUND The compound CEP-751 (KT-6587), a potent and selective inhibitor of the Trk family of tyrosine kinases, has been shown… (More)
Is this relevant?
2000
2000
BACKGROUND Prostatic cancer cells are lethal because they acquire the ability to activate survival pathways that do not require… (More)
Is this relevant?
1999
1999
Neuroblastoma (NBL) and medulloblastoma (MBL) are tumors of the neuroectoderm that occur in children. NBL and MBL express Trk… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
1999
1999
The indolocarbazole analogue CEP-751 is a potent and selective tyrosine kinase inhibitor of the neurotrophin-specific trk… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
1998
1998
Advanced prostate cancer remains largely incurable, primarily because the very low growth fraction present in these tumors makes… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
1997
1997
The present report describes the in vitro and in vivo profile of CEP-751, a novel receptor tyrosine kinase inhibitor. CEP-751 at… (More)
Is this relevant?